JSPRW
Jasper Therapeutics, Inc.
Nasdaq Biological Products, (No Diagnostic Substances)
Emerging growth company

Key Financials

Operating Income
$-83883000
↓ 10.0%
Total Assets
$35.8M
↓ 55.2%
Total Liabilities
$31.6M
↑ 73.5%
Shareholders' Equity
$4.2M
↓ 93.3%
Cash & Equivalents
$28.7M
↓ 59.9%
EPS (Diluted)
$-3.95
↑ 19.2%
Net Income
$-75801000
↓ 6.4%
Operating Cash Flow
$-77161000.00
↓ 23.3%

Recent SEC Filings

Form Type Filed Date Link
8-K/A 10/1/2026 View on SEC
8-K 9/28/2026 View on SEC
25-NSE 9/24/2026 View on SEC
DEF 14A 9/4/2026 View on SEC
8-K 8/26/2026 View on SEC
PRE 14A 8/24/2026 View on SEC
SCHEDULE 13G 8/17/2026 View on SEC
8-K 8/14/2026 View on SEC
10-Q 8/14/2026 View on SEC
D 8/5/2026 View on SEC

Company Information

Field Value
Ticker JSPRW
Company Name Jasper Therapeutics, Inc.
CIK 1788028
Sector Biological Products, (No Diagnostic Substances)
Industry
Emerging growth company
Exchange Nasdaq
SIC Code 2836
SIC Description Biological Products, (No Diagnostic Substances)
Entity Type operating
Fiscal Year End 1231
State of Incorporation DE
Phone 6505491400